𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin

✍ Scribed by Dr. Daniel Tarsy

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
217 KB
Volume
12
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Seventy‐six consecutive patients with cervical dystonia (CD) treated with botulinum toxin were assessed with the Tsui rating scale, the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), and a global scale of improvement. Tsui, TWSTRS, and TWSTRS subscale scores all showed significant improvement. Tsui and TWSTRS score reduction rates correlated significantly with each other, and each correlated with the global scale. Analysis of these scales and TWSTRS subscales indicates that an objective scale of severity such as either the Tsui rating scale or TWSTRS severity subscale used in conjunction with the TWSTRS pain subscale adequately assesses improvement of CD following treatment with botulinum toxin.

πŸ“œ SIMILAR VOLUMES

Comparison of treatment of tardive dysto
Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A
✍ Dr. Allison Brashear; Walter T. Ambrosius; George J. Eckert; Eric R. Siemers πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 337 KB

To compare clinical parameters of patients treated with botulinum toxin type A (BTX) for treatment of idiopathic cervical dystonia (ICD) and for tardive cervical dystonia (TCD), we studied 156 patients (149 with ICD and 7 with TCD) who were treated with serial injections of BTX over 5 years. We hypo

Long-term botulinum toxin treatment incr
Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia
✍ Inger Marie Skogseid; Jo RΓΈislien; BjΓΈrgulf Claussen; Emilia Kerty πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 153 KB

## Abstract We examined the impact of cervical dystonia (CD) and long‐term botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of long‐term treatment were obtained from 62 CD patients aged 31–66 years (med

Botulinum toxin treatment of lateral axi
Botulinum toxin treatment of lateral axial dystonia in parkinsonism
✍ Laura Bonanni; Astrid Thomas; Sara Varanese; Vincenzo Scorrano; Marco Onofrj πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 130 KB

## Abstract Lateral axial dystonia (LAD) has been described in patients with Parkinson's disease (PD), but treatment might be more controversial than treatment of LAD in other neurological conditions. Our study was designed as a blinded cross‐over with botulinum toxin (BTX) and placebo in order to